16 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

17 Clinical utility of ivabradine in cardiovascular disease management: current status

18 Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report

19 Cardiovascular disease among patients attending a specialist diabetes clinic in Jamaica

20 High-density lipoproteins: a novel therapeutic target for cardiovascular disease

21 A Cox-Based Risk Prediction Model for Early Detection of Cardiovascular Disease: Identification of Key Risk Factors for the Development of a 10-Year CVD Risk Prediction

22 SHOX Duplication and Tall Stature in a Patient with Xq Deletion and Vascular Disease

23 In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil

24 Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases

25 Dilating Vascular Diseases: Pathophysiology and Clinical Aspects

26 Clinical utility of ivabradine in cardiovascular disease management: current status

27 Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report

28 Cardiovascular disease among patients attending a specialist diabetes clinic in Jamaica

29 High-density lipoproteins: a novel therapeutic target for cardiovascular disease

30 Ethnic disparities in prevalence and clustering of cardiovascular disease risk factors in rural Southwest China.

31 Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.

32 YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

33 Pregnancy-related events associated with subclinical cardiovascular disease burden in late midlife: SWAN.

34 Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.

35 Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.

36 Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.

37 Multimorbidity Analysis According to Sex and Age towards Cardiovascular Diseases of Adults in Northeast China

38 Walking pace is inversely associated with risk of death and cardiovascular disease: The Physicians' Health Study.

39 Development and Assessment of a Social Network Service-Based Lifestyle-Modification Program for Workers at High Risk of Developing Cardiovascular Disease.

40 High risk for cardiovascular disease in postmenopausal breast cancer survivors.

41 The relationship between psychological states and health perception in individuals at risk for cardiovascular disease.

42 Association of Concurrent Changes in Metabolic Health and Weight on Cardiovascular Disease Risk: A Nationally Representative Cohort Study.

43 Examining the Prevalence of Adverse Childhood Experiences and Associated Cardiovascular Disease Risk Factors Among Low-Income Uninsured Adults.

44 [Interpretation and comments about the rise and fall of aspirin in the primary prevention of cardiovascular disease].

45 Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129.

46 Obesity matters but is not perceived: A cross-sectional study on cardiovascular disease risk factors among a population-based probability sample in rural Zambia.

47 Vitamin D and cause-specific vascular disease and mortality: a Mendelian randomisation study involving 99,012 Chinese and 106,911 European adults.

48 Gestational diabetes mellitus in mothers and long term cardiovascular disease in both parents: Results of over a decade follow-up of the Iranian population

49 Pattern of Vascular Diseases at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

50 A cluster randomised school-based lifestyle intervention programme for the prevention of childhood obesity and related early cardiovascular disease (JuvenTUM 3)

51 Preserve the lower limb in a patient with calcaneal osteomyelitis and severe occlusive peripheral vascular disease by partial calcanectomy

52 A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New Zealand.

53 Monogenetic disorders of the cholesterol metabolism and premature cardiovascular disease

54 DISFUNCIÓN ERÉCTIL: FACTOR PREDICTOR DE ENFERMEDAD CARDIOVASCULAR / Erectile dysfunction: predictor of cardiovascular disease

55 Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.

56 Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.

57 Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

58 Understanding the chinese hui ethnic minority’s information seeking on cardiovascular diseases: A focus group study

59 Cardiovascular disease in the literature: A selection of recent original research papers

60 Holocaust Survival and the Long-term Risk of Cardiovascular Disease in the Elderly.

61 Cardiovascular disease and long-term occupational exposure to ultrafine particles: A cohort study of airport workers.

62 Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.

63 Associations of cardiovascular disease and depression with memory related disease: A Chinese national prospective cohort study.

64 Association of motoric cognitive risk syndrome with cardiovascular disease and risk factors: Results from an original study and meta-analysis

65 Sex- and Poverty-Specific Patterns in Hiv-Associated Cardiovascular Disease Mortality in New York City, 2007-2017.

66 Lack of association between TCF7L2 gene variants and type 2 diabetes mellitus in a Brazilian sample of patients with the risk for cardiovascular disease.

67 Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study.

68 Investigations of the impact of polluted natural waters on cardiovascular diseases and development of integrated prevention system

69 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.

70 Sodium Intake during Pregnancy, but Not Other Diet Recommendations Aimed at Preventing Cardiovascular Disease, Is Positively Related to Risk of Hypertensive Disorders of Pregnancy.

71 Corrigendum to: Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease (Food Science & Nutrition, (2018), 6, 6, (1770-1777), 10.1002/fsn3.734)

72 What drives adoption of a computerised, multifaceted quality improvement intervention for cardiovascular disease management in primary healthcare settings? A mixed methods analysis using normalisation process theory.

73 Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.

74 Implications of Necroptosis for Cardiovascular Diseases.

75 Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

76 Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

77 Why patients with cardiovascular risks go to dentists. Is there sufficient evidence of influence of periodontal therapy on cardiovascular disease?

78 Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013.

79 Dietary fatty acids-effects on cardiovascular disease.

80 Harms and Benefits of Using Aspirin for Primary Prevention of Cardiovascular Disease: A Narrative Overview.

81 Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.

82 Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.

83 Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials.

84 Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

85 A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.

86 Performance-based prediction of chronic kidney disease using machine learning for high-risk cardiovascular disease patients

87 THE USE OF NEURAL NETWORKS FOR THE AUTOMATIC ANALYSIS OF ELECTROCARDIOGRAMS IN DIAGNOSIS OF CARDIOVASCULAR DISEASES

88 Importance of electronic medical record-facilitated pathways to optimize care for vascular disease management

89 Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovascular Disease.

90 Gender Differences in Patient-Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease.

91 Reducing Cardiovascular Disease Risk for Employees Through Participation in a Wellness Program.

92 The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

93 Stress at intellectual work and cardiovascular diseases in women at non-mobility working age.

94 Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease.

95 A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention.

96 A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention

97 Genetic architecture of human plasma lipidome and its link to cardiovascular disease.

98 Cardiovascular disease research in the Arab world: a scoping review from seven Arab countries (2000–2018)

99 Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013.

100 Epidemiology in diabetes mellitus and cardiovascular disease.

101 Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.

Keyword Connections

Journals

Research Groups

Bibliographies